16.01.2013 Views

2010Annual Report - Schneider Electric CZ, s.r.o.

2010Annual Report - Schneider Electric CZ, s.r.o.

2010Annual Report - Schneider Electric CZ, s.r.o.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1.11 - Impairment of assets<br />

In accordance with IAS 36 – Impairment of Assets – the Group<br />

assesses the recoverable amount of its long-lived assets as follows:<br />

• for all property, plant and equipment subject to depreciation and<br />

intangible assets subject to amortisation, the Group carries out a<br />

review at each balance sheet date to assess whether there is any<br />

indication that they may be impaired. Indications of impairment<br />

are identifi ed on the basis of external or internal information. If<br />

such an indication exists, the Group tests the asset for impairment<br />

by comparing its carrying amount to the higher of fair value minus<br />

costs to sell and value in use;<br />

• non-amortisable intangible assets and goodwill are tested for<br />

impairment at least annually and whenever there is an indication<br />

that the asset may be impaired.<br />

Value in use is determined by discounting future cash fl ows that will<br />

be generated by the tested assets, generally over a period of not<br />

more than fi ve years. These future cash fl ows are based on Group<br />

management’s economic assumptions and operating forecasts. The<br />

discount rate corresponds to the Group’s weighted average cost<br />

of capital (WACC) at the measurement date plus a risk premium<br />

depending on the region in question. The WACC stood at 8.4% at<br />

December 31, 2010, a slight increase on the 8.1% at December 31,<br />

2009. This rate is based on (i) a long-term interest rate of 3.8%,<br />

corresponding to the average interest rate for 10 year OAT treasury<br />

bonds over the past few years, (ii) the average premium applied to<br />

fi nancing obtained by the Group in the fourth quarter of 2010, and<br />

(iii) the weighted country risk premium for the Group’s businesses in<br />

the countries in question.<br />

The perpetuity growth rate was 2%, unchanged on the previous<br />

fi nancial year.<br />

Impairment tests are performed at the level of the cash-generating<br />

unit (CGU) to which the asset belongs. A cash-generating unit is the<br />

smallest group of assets that generates cash infl ows that are largely<br />

independent of the cash fl ows from other assets or groups of assets.<br />

The cash-generating units correspond to the Power, Industry, IT,<br />

Buildings, CST businesses, which have operated as divisions since<br />

the reorganisation on January 1, 2010. Entities were reallocated to<br />

the new CGUs at the lowest possible level on the basis of their<br />

business activities; in the case of mixed entities, their assets were<br />

allocated to each business (Power and Industry mainly) pro-rata to<br />

their revenue in that business.<br />

At end-2010, the Distribution business acquired from Areva on<br />

June 7, 2010 wasn’t allocated to any specifi c CGU and hadn’t yet<br />

been tested given the recent date of acquisition. Nevertheless, as<br />

2010 results were slightly ahead of the forecasts in the business plan<br />

used for the purposes of the acquisition, the Group does not feel<br />

there that there are impairment risks with respect to these assets at<br />

the balance sheet date.<br />

The WACC used to determine the value in use of each CGU was<br />

9.0% for Power and Industry, 9.2% for IT, 8.6% for Buildings and<br />

CST.<br />

Goodwill is allocated when initially recognised. The CGU allocation is<br />

done on the same basis as used by Group management to monitor<br />

operations and assess synergies deriving from acquisitions. As a<br />

result of the organisational changes effective January 1, 2010, the<br />

allocation of goodwill has been changed to refl ect the new operating<br />

segments defi ned in accordance with the newly issued IFRS 8. This<br />

modifi cation did not have an impact on asset impairment.<br />

CONSOLIDATED FINANCIAL STATEMENTS<br />

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS<br />

Where the recoverable amount of an asset or CGU is lower than<br />

its book value, an impairment loss is recognised. Where the tested<br />

CGU comprises goodwill, any impairment losses are fi rstly deducted<br />

therefrom.<br />

1.12 - Non-current financial assets<br />

Investments in non-consolidated companies are classified as<br />

available-for-sale fi nancial assets. They are initially recorded their<br />

cost of acquisition and subsequently measured at fair value, when<br />

fair value can be reliably determined.<br />

The fair value of equity instruments quoted in an active market may<br />

be determined reliably and corresponds to the quoted price on the<br />

balance sheet date (Level 1 input as described in the amendment to<br />

IFRS 7 – Improving Disclosures about Financial Instruments).<br />

In cases where fair value cannot be reliably determined (Level 3<br />

inputs), the equity instruments are measured at net cost of any<br />

accumulated impairment losses. The recoverable amount is<br />

determined with reference to the Group’s share in the entity’s net<br />

assets along with its expected future profi tability and outlook. This<br />

rule is applied in particular to unlisted equity instruments.<br />

Changes in fair value are accumulated in equity under “Other<br />

reserves” up to the date of sale, at which time they are recognised<br />

in the income statement. Unrealised losses on assets that are<br />

considered to be permanently impaired are recorded under “Finance<br />

costs and other fi nancial income and expense, net”.<br />

Loans, recorded under “Other non-current fi nancial assets”, are<br />

carried at amortised cost and tested for impairment where there<br />

is an indication that they may have been impaired. Long-term<br />

fi nancial receivables are discounted when the impact of discounting<br />

is considered signifi cant.<br />

1.13 - Inventories and work in process<br />

Inventories and work in process are stated at the lower of their entry<br />

cost (acquisition cost or production cost generally determined by the<br />

weighted average price method) or of their estimated net realisable<br />

value.<br />

Net realisable value corresponds to the estimated selling price net of<br />

remaining expenses to complete and/or sell the products.<br />

Inventory impairment losses are recognised in “Cost of sales” for<br />

the material component and in “Selling, general and administrative<br />

expenses” for the fi nished products.<br />

The cost of work in process, semi-fi nished and fi nished products,<br />

includes the cost of materials and direct labor, subcontracting costs,<br />

all production overheads based on normal capacity utilisation rates<br />

and the portion of research and development costs related to the<br />

production process (corresponding to the amortisation of capitalised<br />

projects in production and product and range maintenance costs).<br />

2010 REGISTRATION DOCUMENT SCHNEIDER ELECTRIC 163<br />

5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!